The chemicals listed are broadly grouped into what may be described as Cdc25A activators. These compounds act primarily through the modulation of upstream signaling pathways that indirectly lead to the activation or stabilization of Cdc25A. These pathways include, but are not limited to, Ras/Raf/MEK/ERK, PKA, PKC, PP2A, and PI3K/AKT. Several of these chemicals serve as inhibitors or activators of these pathways, which ends up having a downstream effect on Cdc25A. For instance, EGF and PMA activate pathways that can stabilize Cdc25A, whereas inhibitors like Okadaic Acid and Calyculin A prevent the dephosphorylation and inactivation of the protein.
These chemicals represent diverse mechanistic classes, including growth factors (EGF), natural compounds (Forskolin, Genistein), and synthetic inhibitors (Roscovitine, LY294002). The variability in their chemical structures and mechanisms highlights the complexity of the cellular processes that they influence. Despite the diversity, they all share the common feature of modulating cellular pathways that can result in the activation or stabilization of Cdc25A. Whether through the inhibition of phosphatases like PP1 and PP2A or through the modulation of kinases such as PKA, PKC, and MAPKs, these chemicals underline the complex regulatory network that controls Cdc25A activity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin raises cAMP levels and thereby stimulates the PKA pathway, which can in turn stabilize Cdc25A. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA can activate PKC, leading to downstream effects that may include the stabilization and activation of Cdc25A. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid is a PP2A inhibitor, thus its presence can prevent the dephosphorylation and inactivation of Cdc25A. | ||||||
Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $94.00 $265.00 | 42 | |
Roscovitine inhibits CDKs, creating a feedback loop that can result in increased Cdc25A activity. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
By inhibiting PP1 and PP2A, Calyculin A can stabilize the active, phosphorylated form of Cdc25A. | ||||||
H-89 dihydrochloride | 130964-39-5 | sc-3537 sc-3537A | 1 mg 10 mg | $94.00 $186.00 | 71 | |
H-89 is a PKA inhibitor, its presence can influence pathways that stabilize Cdc25A. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
As a PI3K inhibitor, LY294002 can indirectly influence AKT and downstream targets including Cdc25A. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 inhibits p38 MAPK, which can indirectly lead to stabilization of Cdc25A. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 inhibits JNK, thereby can influence downstream targets that may stabilize or activate Cdc25A. | ||||||